Laurent Pharmaceuticals
- Biotech or pharma, therapeutic R&D
Laurent Pharma is a clinical stage (Phase 2) private company developing LAU-7b, an oral small molecule drug with established Phase 2 proof-of-concept in dry form of macular degeneration. Capitalizing on LAU-7b advanced clinical package and the clinically validated mechanism of action, the company is preparing to start a Phase 2 program in Stargardt Disease.



